Author Archives: Wilmer Balmocena

March 9, 2021
FeaturedPress Release

Recognized for innovation in powering small molecule drug discovery with AI, Atomwise among the Top-10 in Biotechnology category SAN FRANCISCO, Calif. — March 9, 2021 —  Atomwise, a leader in using artificial intelligence (AI) for small -molecule drug discovery, today announced it has been named to Fast Company’s prestigious annual list of the World’s Most […]

Read Article
March 8, 2021
FeaturedIn The News
Read Article
January 12, 2021
In The News
Read Article
December 29, 2020
In The News
Read Article
December 22, 2020
In The News
Read Article
December 21, 2020
In The News

After raising $123 million this past summer to fuel its artificial-intelligence-based drug design work, Atomwise has helped launch a new company focused on uncovering treatments in immuno-oncology.

Read Article